Amanote Research

Amanote Research

    RegisterSign In

Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.2009.3088
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
Date

May 1, 2009

Authors
Irina Petrache
Publisher

Dove Medical Press Ltd.


Related search

Alpha-1-Antitrypsin Deficiency

2020English

Alpha‐1‐Antitrypsin Deficiency

English

Alpha-1 Antitrypsin Deficiency

Journal of insurance medicine (New York, N.Y.)
Medicine
2015English

Alpha 1-Antitrypsin-Labor Und Alpha 1-Antitrypsin-Register

Pneumologie
MedicinePulmonaryRespiratory Medicine
2004English

Orphan Designation: Alpha-1 Antitrypsin (Inhalation Use), Treatment of Emphysema Secondary to Congenital Alpha-1-Antitrypsin Deficiency

Case Medical Research
2019English

Alpha-1 Antitrypsin Deficiency in Patients With Chronic Hepatitis

Turkish Journal of Gastroenterology
Gastroenterology
2012English

Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2016English

Alpha 1-Antitrypsin Deficiency and Liver Disease.

BMJ
1981English

Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy